BioAdvice is a GLP and GMP compliant preclinical Contract Research Organisation (CRO) located near Copenhagen, Denmark. The company was established in 1999 and is now driven by a young energetic team of skilled Study Directors, Veterinarians, Animal Technicians and Laboratory Technician.


We offer services within multiple areas of preclinical in-vivo drug testing, with emphasis on metabolism, inflammation and dermatology. We have specialized within pharmacokinetic (PK) and pharmacodynamic (PD) studies in multiple species; mice, rats, rabbits, minipigs, SPF pigs and beagle dogs. Dosing is performed at clinically relevant intervals by various administration routes as; intravenously, intramuscularly, subcutaneously and intradermally. Blood samples will be taken for analysis of test substances aiming at elucidating absorption, distribution, metabolism and excretion of the substances. Blood samples may also be taken for clinical chemistry and/or haematology.


We have a broad portfolio of performed studies, where our experiences and observations, help us continuously improve study designs and refine our technical procedures. E.g.


  • Pharmacokinetic and pharmacodynamic profiling
  • Imaging services; Ultrasound, X-ray (C-arm), MRI (joint pathology)
  • Wound healing studies in pigs
  • Inflammatory tests
  • Toxicology studies, single and repeated dosing, local toxicity tests
  • Batch-release tests according to GMP incl. antigenic impurities in guinea pigs
  • Medical device testing
  • Surgical training


The modern facility and highly qualified monitoring skills at BioAdvice ensures high ethical standards with thorough individualised attention to any animal in your studies.

We aim at giving our customers high ethical standards, flexibility and high quality at any time.

BIOADVICE A/S, LYSHØJVEJ 21, 3650 ØLSTYKKE, DENMARK   +4538252015   BIOADVICE@BIOADVICE.DK

BIOADVICE A/S, LYSHØJVEJ 21, 3650 ØLSTYKKE, DENMARK

+4538252015

BIOADVICE@BIOADVICE.DK

Go to article: Home | The absence of antivenomGo to article: In this issueGo to article: Daiichi JitsugyoGo to article: ContentsGo to article: Capsugel Company InsightGo to article: CapsugelGo to article: NewsGo to article: Scandinavian Health Ltd.Go to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: The pharma industry briefingGo to article: TSS Company InsightGo to article: TSS ABGo to article: Action Medical Research: celebrating decades of discovery Go to article: Swiss WorldCargoGo to article: Gerteis Company InsightGo to article: GerteisGo to article: Moehs Iberica SLGo to article: Owen MumfordGo to article: How government policy has shaped China’s pharma phenomenonGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Novo NordiskGo to article: Snake venom in pharma; access to antivenom is a topic that needs attentionGo to article: Phoenix Group Company InsightGo to article: Phoenix Group Go to article: ME Logistic ServicesGo to article: Discussing drug policy reform with psychedelics campaigner Amanda FeildingGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Aseptic TechnologiesGo to article: False flags: are search engines benefiting rogue online pharmacies?Go to article: CBDepot Company InsightGo to article: CBDepotGo to article: Wilco Company Insight Go to article: WilcoGo to article: The Mighty: how patients and pharma align in the age of social media Go to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: MicronovaGo to article: Inside Italy’s pharmaceutical industry Go to article: KlingeGo to article: BEAGo to article: Erdmann Design SwitzerlandGo to article: Inside the UK’s first vaccines innovation centreGo to article: AralabGo to article: Applikon BiotechnologyGo to article: BaxterGo to article: NymiGo to article: Fostering closer collaboration between manufacturing & regulatory functionsGo to article: EmisphereGo to article: SephaGo to article: Contract Pharmaceuticals Limited CanadaGo to article: EventsGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Next issueGo to article: PolpharmaGo to article: BioAdvice